Prothena Corp plc License Agreements
14 Contracts & Agreements
- Global License Agreement, dated as of (Filed With SEC on August 8, 2024)
- Global License Agreement, dated as of July 5, 2023, by and between Prothena Biosciences Limited and Celgene Switzerland LLC (Filed With SEC on November 2, 2023)
- U.S. License Agreement, dated as of July 30, 2021, as amended on August 12, 2021 and September 8, 2021, by and between Prothena Biosciences Limited and Celgene Switzerland LLC (Filed With SEC on November 4, 2021)
- Amendment No. 2 to License, Development, and Commercialization Agreement, entered into on December 11, 2013, among Prothena Biosciences Limited, Prothena Biosciences Inc, F.... (Filed With SEC on November 4, 2021)
- License Agreement, dated as of March 1, 2020, between Prothena Biosciences Limited and F. Hoffmann-La Roche Ltd (Filed With SEC on May 6, 2020)
- Understanding Related to License, Development, and Commercialization Agreement, dated as of March 1, 2020, among Prothena Biosciences Limited, Prothena Biosciences Inc, F.... (Filed With SEC on May 6, 2020)
- Amendment to License, Development, and Commercialization Agreement, entered into on October 1, 2019, among Prothena Biosciences Limited, Prothena Biosciences Inc, F. Hoffman-La... (Filed With SEC on March 3, 2020)
- Exclusive License Agreement, dated as of July 25, 2016, between University Health Network and Prothena Biosciences Limited (Filed With SEC on May 9, 2018)
- License Agreement Amendment Number One, dated as of January 15, 2014, to License Agreement dated as of November 4, 2013, between The Regents of the University of California and... (Filed With SEC on May 9, 2018)
- License Agreement, dated as of November 4, 2013, between The Regents of the University of California and Neotope Biosciences Limited (Filed With SEC on May 9, 2018)
- LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN NEOTOPE BIOSCIENCES LIMITED AND PROTHENA BIOSCIENCES INC, on the one hand, AND F. HOFFMANN-LA ROCHE LTD AND... (Filed With SEC on March 7, 2014)
- AMENDMENT NUMBER ONE AMENDED AND RESTATED INTELLECTUAL PROPERTY LICENSE AND CONTRIBUTION AGREEMENT (Filed With SEC on September 30, 2013)
- INTELLECTUAL PROPERTY LICENSE AND CONVEYANCE AGREEMENT AMONG NEOTOPE BIOSCIENCES LIMITED AND ELAN PHARMA INTERNATIONAL LIMITED AND ELAN PHARMACEUTICALS, INC. Dated as of December... (Filed With SEC on December 21, 2012)
- AMENDED AND RESTATED INTELLECTUAL PROPERTY LICENSE AND CONTRIBUTION AGREEMENT AMONG NEOTOPE BIOSCIENCES LIMITED AND ELAN PHARMA INTERNATIONAL LIMITED AND ELAN PHARMACEUTICALS,... (Filed With SEC on December 21, 2012)
